VON WILLEBRAND DISEASE (VWD), TYPE 2
Clinical trials for VON WILLEBRAND DISEASE (VWD), TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD), TYPE 2 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot aims to stop bleeding in rare blood disorder
Disease control Recruiting nowThis study is testing a new drug called BT200 for adults with type 2B von Willebrand disease, a rare inherited bleeding disorder. Participants will give themselves a weekly injection of either the drug or a placebo for four weeks, then switch after a break. The main goal is to se…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to control bleeding disorder
Disease control Recruiting nowThis early-stage study is testing a new drug called HMB-002 in adults with Von Willebrand Disease, a genetic bleeding disorder. The main goals are to check if the drug is safe, determine the right dose, and see if it helps reduce bleeding episodes. Researchers will first test sin…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Scientists track bleeds in rare blood disorder
Knowledge-focused Recruiting nowThis study aims to collect detailed information about how often people with Von Willebrand Disease (VWD) experience bleeding, how it affects their lives, and what treatments they use. Researchers will follow about 200 participants for 4 to 12 months, checking in regularly to trac…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Sponsor: Hemab ApS • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC